resveratrol has been researched along with Biliary Cirrhosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cui, Y; Fu, X; Jiang, T; Li, Y; Liang, Y; Qian, J; Tao, G; Xi, Y; Xu, G; Yang, Z | 1 |
Ara, C; Ay, S; Coban, S; Harputluoglu, M; Karabulut, AB; Kirimlioglu, H; Kirimlioglu, V; Yilmaz, S | 1 |
2 other study(ies) available for resveratrol and Biliary Cirrhosis
Article | Year |
---|---|
Sirtuin 1 activation alleviates primary biliary cholangitis via the blocking of the NF-κB signaling pathway.
Topics: Animals; Cells, Cultured; Cytokines; Disease Models, Animal; Humans; Inflammation Mediators; Liver; Liver Cirrhosis, Biliary; Macrophages; Male; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; NF-kappa B; Poly I-C; Resveratrol; Signal Transduction; Sirtuin 1 | 2020 |
Protective effect of resveratrol against oxidative stress in cholestasis.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Cholestasis; Chronic Disease; Cytokines; Cytoprotection; Glutathione; Injections, Intraperitoneal; Liver; Liver Cirrhosis, Biliary; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Rats; Resveratrol; Stilbenes | 2005 |